Description
This naphthalene exhibits anticancer activity; in fibrosarcoma and breast cancer cells, it increases expression of STAT1 and IFN regulatory factor 1 and enhances the ability of IFNγ to inhibit cell proliferation.
Product Unit Size | Cost | Quantity | Stock |
---|
This naphthalene exhibits anticancer activity; in fibrosarcoma and breast cancer cells, it increases expression of STAT1 and IFN regulatory factor 1 and enhances the ability of IFNγ to inhibit cell proliferation.
Cas No. | 65182-56-1 |
---|---|
Purity | ≥98% |
Formula | C14H10N2O |
Formula Wt. | 222.24 |
IUPAC Name | 6-(1H-1,8-naphthyridin-2-ylidene)cyclohexa-2,4-dien-1-one |
Solubility | Ethanol (7 mg/mL), DMSO (50 mg/mL) |
Appearance | Red Crystals |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Lynch RA, Etchin J, Battle TE, et al. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells. Cancer Res. 2007 Feb 1;67(3):1254-61. PMID: 17283162.
Xanthine derivative; adenosine A2 antagonist, P...
Nonoxynol surfactant.
Selective inhibitor of the delta isoform of PI3...
MAO-A inhibitor.
Synthetic peptide, vasopressin analog; AVPR1 ag...
5-HT2A and TRPV1 antagonist, potential α1-adre...
L-type Ca2+ channel blocker.
Phenylpropanoid found in Castilleja, Verbena, V...
Antioxidant shown to improve renal function.
Synthetic glycyrrhetinic acid derivative; 11β-...
AurK, FLT3, Abl inhibitor.
Laminin-derived nonapeptide.
5-HT1A agonist, D2, 5-HT1D antagonist.
BHA derivative.
Peptide, c-Kit ligand fragment.
HSP90 inhibitor.
PARP inhibitor.
BH3 mimetic; Bcl-2, Bxl-xl, Bcl-w inhibitor.
Voltage-gated Na+ channel blocker, mAChR antago...
p110α PI3K inhibitor.